Lawrence Otto Klein Crispr Therapeutics Ag (CRSP) insider trading activity

Lawrence Otto Klein is CBO & COO of CRISPR Therapeutics AG. Currently has a direct ownership of 26,797 shares of CRSP, which is worth approximately $1.64 Million. The most recent transaction as insider was on Jan 02, 2019, when has been sold 20,000 shares (Restricted Stock Units) at a price of $29.87 per share, resulting in proceeds of $597,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.8K

0% 3M change

0% 12M change

Total Value Held $1.64 Million

Lawrence Otto Klein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 02 2019	BUY Grant, award, or other acquisition	$597,400 $29.87 p/Share	20,000 Added 50.0%	20,000 Restricted Stock Units

Also insider at

DYN

Dyne Therapeutics, Inc. Healthcare

Director

JSPR

Jasper Therapeutics, Inc. Healthcare

Director

ABIO

ARCA biopharma, Inc. Healthcare

Chief Executive Officer

AVTE

Aerovate Therapeutics, Inc. Healthcare

LOK